This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Prescription Drugs

Controlling Drug Cost Growth

PROLOGUE: The dramatic rise in life expectancy for Americans over the course of the twentieth century was augured by an explosion of medical innovation and technology that included the development of new drugs aimed at eradicating and lessening the effects of a wide range of life-threatening and debilitating diseases. And with a staggering array of new drugs under development and a growing list of funders willing to underwrite the risky business of developing ever more exotic and more powerful drugs, there seems to be no end in sight to the stream of new drugs that will enter the consumer market . . . [Full Text of this Article]

                      What's this?